Ghent University Academic Bibliography

Conference Paper
open access

Prostate-specific Membrane Antigen-targeted Radionuclide Therapy as Adjunct to Immune Checkpoint Inhibition in an Immunocompetent Murine Model for Oral Squamous Cell Carcinoma

Michaël Henrotte (UGent) , David Creytens (UGent) , Filip De Vos (UGent) , Benedicte Descamps (UGent) , Lindsey Devisscher (UGent) , Wouter Huvenne (UGent) , Ken Kersemans (UGent) , Sara Neyt (UGent) , Sylvie Rottey (UGent) , Michael Saerens (UGent) , et al.

(2025) 11th European Congress on Head and Neck Oncology.

Add to list

Evaluation of [111In]FAPI-46 via dual-isotope SPECT imaging as a predictive radioligand for [177Lu]FAPI-46 biodistribution and dosimetry in mice

Amber Meskens (UGent) , Sara Neyt (UGent) , Michaël Henrotte (UGent) , Jens Debacker (UGent) , Christian Vanhove (UGent) and Filip De Vos (UGent)

(2025) EMIM 2025 : European Molecular Imaging Meeting : 20th Annual Meeting of the European Society for Molecular Imaging, Abstracts.

Add to list

Journal Article
A2
open access

The development of 177Lu-DOTA-CC-PSMA following a unified “Click Chemistry” protocol of synthesizing metal nuclide-conjugated radiopharmaceuticals

Xiaobei Zheng, Shuai Xue, Zhongqi Zhao, Shuxin Jin, Shuhua He, Lina Jia, Zheng Li, Christian Vanhove (UGent) , Filip De Vos (UGent) , Zijun Kuang, et al.

(2024) EJNMMI RADIOPHARMACY AND CHEMISTRY. 9(1).

Add to list

Prostate-specific membrane antigen as a potential theranostic target in a syngeneic immunocompetent murine model for oral squamous cell carcinoma

Michaël Henrotte (UGent) , David Creytens (UGent) , Hilde De Cock (UGent) , Filip De Vos (UGent) , Benedicte Descamps (UGent) , Lindsey Devisscher (UGent) , Wouter Huvenne (UGent) , Ken Kersemans (UGent) , Lieselotte Moerman (UGent) , Christian Vanhove (UGent) , et al.

(2024) OncoPoint Symposium, 10th, Abstracts.

Add to list

Prostate-specific membrane antigen-targeted radionuclide therapy as a novel therapeutic approach in a syngeneic immunocompetent murine model for oral squamous cell carcinoma

Michaël Henrotte (UGent) , David Creytens (UGent) , Filip De Vos (UGent) , Benedicte Descamps (UGent) , Lindsey Devisscher (UGent) , Wouter Huvenne (UGent) , Ken Kersemans (UGent) , Sara Neyt (UGent) , Christian Vanhove (UGent) and Jens Debacker (UGent)

(2024) EANM'24 : 37th Annual Congress of the European Association of Nuclear Medicine.

Add to list

Journal Article
A1
open access

Preclinical comparative study of [18F]AlF-PSMA-11 and [18F]PSMA-1007 in varying PSMA expressing tumors

Sarah Piron, Jeroen Verhoeven (UGent) , Jan Courtyn (UGent) , Ken Kersemans (UGent) , Benedicte Descamps (UGent) , Leen Pieters (UGent) , Anne Vral (UGent) , Christian Vanhove (UGent) and Filip De Vos (UGent)

(2022) SCIENTIFIC REPORTS. 12(1).

Add to list

Journal Article
A1
open access

Recent advancements in 18F-labeled PSMA targeting PET radiopharmaceuticals

Sarah Piron, Jeroen Verhoeven (UGent) , Christian Vanhove (UGent) and Filip De Vos (UGent)

(2022) NUCLEAR MEDICINE AND BIOLOGY. 106-107. p.29-51

Add to list

18F-PSMA-11 Versus 68Ga-PSMA-11 positron emission tomography/computed tomography for staging and biochemical recurrence of prostate cancer : a prospective double-blind randomised cross-over trial

Kathia De Man (UGent) , Nick Van Laeken (UGent) , Vanessa Schelfhout (UGent) , Wolfgang P. Fendler, Bieke Lambert (UGent) , Ken Kersemans (UGent) , Sarah Piron, Nicolaas Lumen (UGent) , Karel Decaestecker (UGent) , Valerie Fonteyne (UGent) , et al.

(2022) EUROPEAN UROLOGY. 82(5). p.501-509

Add to list

Journal Article
A1
open access

Accelerated HF‐rTMS modifies SERT availability in the subgenual anterior cingulate cortex : a canine [11C]DASB study on the serotonergic system

Yangfeng Xu (UGent) , Mitchel Kappen, Kathelijne Peremans (UGent) , Dimitri De Bundel, Ann Van Eeckhout, Nick Van Laeken (UGent) , Filip De Vos (UGent) , André Dobbeleir, Jimmy Saunders (UGent) and Chris Baeken (UGent)

(2022) JOURNAL OF NUCLEAR MEDICINE. 11(6).

Add to list

Journal Article
A1
open access

Assessment of the effect of therapy in a rat model of glioblastoma using [18F]FDG and [18F]FCho PET compared to contrast-enhanced MRI

Julie Bolcaen, Benedicte Descamps (UGent) , Karel Deblaere (UGent) , Filip De Vos (UGent) , Tom Boterberg (UGent) , Giorgio Hallaert (UGent) , Caroline Van den Broecke (UGent) , Christian Vanhove (UGent) and Ingeborg Goethals (UGent)

(2021) PLOS ONE. 16(3).

Academic Bibliography

Prostate-specific Membrane Antigen-targeted Radionuclide Therapy as Adjunct to Immune Checkpoint Inhibition in an Immunocompetent Murine Model for Oral Squamous Cell Carcinoma

Evaluation of [111In]FAPI-46 via dual-isotope SPECT imaging as a predictive radioligand for [177Lu]FAPI-46 biodistribution and dosimetry in mice

The development of 177Lu-DOTA-CC-PSMA following a unified “Click Chemistry” protocol of synthesizing metal nuclide-conjugated radiopharmaceuticals

Prostate-specific membrane antigen as a potential theranostic target in a syngeneic immunocompetent murine model for oral squamous cell carcinoma

Prostate-specific membrane antigen-targeted radionuclide therapy as a novel therapeutic approach in a syngeneic immunocompetent murine model for oral squamous cell carcinoma

Preclinical comparative study of [18F]AlF-PSMA-11 and [18F]PSMA-1007 in varying PSMA expressing tumors

Recent advancements in 18F-labeled PSMA targeting PET radiopharmaceuticals

18F-PSMA-11 Versus 68Ga-PSMA-11 positron emission tomography/computed tomography for staging and biochemical recurrence of prostate cancer : a prospective double-blind randomised cross-over trial

Accelerated HF‐rTMS modifies SERT availability in the subgenual anterior cingulate cortex : a canine [11C]DASB study on the serotonergic system

Assessment of the effect of therapy in a rat model of glioblastoma using [18F]FDG and [18F]FCho PET compared to contrast-enhanced MRI

Contents

Support

Contact